These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6444958)

  • 21. Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris.
    Morel P; Vienne MP; Beylot C; Bonérandi JJ; Dréno B; Lehucher-Ceyrac D; Slimani S; Dupuy P
    Clin Exp Dermatol; 1999 Sep; 24(5):354-7. PubMed ID: 10564319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythromycin "free base" -a nonsensitizing topical antibiotic for infected dermatoses and acne vulgaris.
    Fisher AA
    Cutis; 1977 Jul; 20(1):17, 26, 30 passim. PubMed ID: 141996
    [No Abstract]   [Full Text] [Related]  

  • 23. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation.
    Schachner L; Pestana A; Kittles C
    J Am Acad Dermatol; 1990 Mar; 22(3):489-95. PubMed ID: 2138180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Topical treatment of acne vulgaris with erythromycin and benzoylperoxide (author's transl)].
    Gloor M; Pfahler E; Neumann W; Höffler U; Hoffmann M; Schmidt U
    Z Hautkr; 1982 Jun; 57(12):867-78. PubMed ID: 6214093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 percent solution in the treatment of acne vulgaris.
    Thomas DR; Raimer S; Smith EB
    Cutis; 1982 Jun; 29(6):624-5, 628-32. PubMed ID: 6213379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris.
    Burke B; Eady EA; Cunliffe WJ
    Br J Dermatol; 1983 Feb; 108(2):199-204. PubMed ID: 6218815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical erythromycin with zinc in acne. A double-blind controlled study.
    Feucht CL; Allen BS; Chalker DK; Smith JG
    J Am Acad Dermatol; 1980 Nov; 3(5):483-91. PubMed ID: 6452464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of topical erythromycin and oral tetracycline in acne vulgaris.
    Rapaport M; Puhvel SM; Reisner RM
    Cutis; 1982 Jul; 30(1):122-6, 130, 132-5. PubMed ID: 6214377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythromycin 2% gel in comparison with clindamycin phosphate 1% solution in acne vulgaris.
    Leyden JJ; Shalita AR; Saatjian GD; Sefton J
    J Am Acad Dermatol; 1987 Apr; 16(4):822-7. PubMed ID: 2952685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Letter: Erythromycin: a nonsensitizing topical antibiotic.
    Fisher AA
    Arch Dermatol; 1976 May; 112(5):732. PubMed ID: 132141
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy and tolerability of combined topical treatment of acne vulgaris with tretinoin and erythromycin in general practice.
    Korting HC; Braun-Falco O
    Drugs Exp Clin Res; 1989; 15(9):447-51. PubMed ID: 2534292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical 5% benzoyl peroxide and 3% erythromycin gel: experience with 191 patients with papulopustular acne.
    Rallis E; Verros C; Katoulis A; Katsarou A
    Acta Dermatovenerol Croat; 2013; 21(3):160-7. PubMed ID: 24183219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The extinction of topical erythromycin therapy for acne vulgaris and concern for the future of topical clindamycin.
    Austin BA; Fleischer AB
    J Dermatolog Treat; 2017 Mar; 28(2):145-148. PubMed ID: 27425633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of systemic erythromycin stearate on the inflammatory lesions and skin surface fatty acids in acne vulgaris.
    Bleeker J; Hellgren L; Vincent J
    Dermatologica; 1981; 162(5):342-9. PubMed ID: 6454598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle.
    Mills O; Thornsberry C; Cardin CW; Smiles KA; Leyden JJ
    Acta Derm Venereol; 2002; 82(4):260-5. PubMed ID: 12361129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial.
    Ozolins M; Eady EA; Avery AJ; Cunliffe WJ; Po AL; O'Neill C; Simpson NB; Walters CE; Carnegie E; Lewis JB; Dada J; Haynes M; Williams K; Williams HC
    Lancet; 2004 Dec 18-31; 364(9452):2188-95. PubMed ID: 15610805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris.
    Chalker DK; Shalita A; Smith JG; Swann RW
    J Am Acad Dermatol; 1983 Dec; 9(6):933-6. PubMed ID: 6227643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Exterior use of erythromycin in acne].
    Rohde BT; Beierdörffer H; Schmersahl P
    Z Hautkr; 1978 Nov; 53(22):819-21. PubMed ID: 152523
    [No Abstract]   [Full Text] [Related]  

  • 39. Topical antibacterial therapy for acne vulgaris.
    Dreno B
    Drugs; 2004; 64(21):2389-97. PubMed ID: 15481998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Double-blind group comparison of topical meclocycline, erythromycin and placebo in the treatment of papulo-pustulosa acne].
    Rozman TA; Klövekorn G; Kompa H
    Z Hautkr; 1984 Dec; 59(23):1623-34. PubMed ID: 6240840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.